Detalhe da pesquisa
1.
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.
N Engl J Med
; 388(17): 1572-1581, 2023 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099340
2.
EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy.
Blood
; 141(7): 743-755, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332176
3.
Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004-2015: A comparative population-based study.
Int J Cancer
; 155(2): 226-239, 2024 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478912
4.
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium.
Blood
; 139(12): 1785-1793, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192312
5.
Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia.
Pharm Res
; 41(4): 711-720, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538970
6.
STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of BCL2 and BCLXL following glucocorticoid treatment.
Haematologica
; 108(3): 732-746, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734930
7.
CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia.
Int J Mol Sci
; 24(17)2023 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686014
8.
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia.
Blood
; 135(17): 1438-1446, 2020 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315382
9.
Late Mortality in Childhood Cancer Survivors according to Pediatric Cancer Diagnosis and Treatment Era in the Dutch LATER Cohort.
Cancer Invest
; 40(5): 413-424, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175864
10.
Depletion of d- and l-asparagine in cerebrospinal fluid in acute lymphoblastic leukemia during PEGasparaginase therapy.
Pediatr Blood Cancer
; 69(11): e29865, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35880973
11.
Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 69(2): e29387, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648216
12.
Infant T-cell acute lymphoblastic leukaemia with t(6;7) (TCRB-MYB) translocation.
Br J Haematol
; 194(3): 613-616, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212378
13.
Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response.
Br J Haematol
; 194(2): 423-432, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34060065
14.
Inotuzumab ozogamicin in infants and young children with relapsed or refractory acute lymphoblastic leukaemia: a case series.
Br J Haematol
; 193(6): 1172-1177, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529389
15.
How I treat infant leukemia.
Blood
; 133(3): 205-214, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30459160
16.
Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model.
Haematologica
; 106(5): 1254-1261, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32327497
17.
Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations
Haematologica
; 106(12): 3046-3055, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33147938
18.
Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker.
Br J Haematol
; 189(3): 442-451, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31883112
19.
Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015.
Br J Haematol
; 189(6): 1093-1106, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030738
20.
Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Haematologica
; 104(4): 738-748, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30381299